ScholarIQanswers from OpenAlex

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling

PaperCitations, authors & open-access status

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling have?

ScholarIQcitation count

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling has 227 citations in the OpenAlex counts ScholarIQ stores.

When was Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling published?

ScholarIQyear

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling has 2003 year in the ScholarIQ index.

What is the open-access status of Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling?

ScholarIQoa status

Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling has green oa status in the ScholarIQ index.

What is the DOI of Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling?

ScholarIQdoi

The DOI for Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling is on the source record.

What is the PMID of Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling?

ScholarIQpmid

The PMID for Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling is on the source record.

What is the OpenAlex record for Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling?

ScholarIQopenalex

The OpenAlex for Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial